-
1
-
-
33746565431
-
Lineage dependency and lineage-survival oncogenes in human cancer
-
L. A. Garraway, W. R. Sellers, Lineage dependency and lineage-survival oncogenes in human cancer. Nat. Rev. Cancer 6, 593-602 (2006).
-
(2006)
Nat. Rev. Cancer
, vol.6
, pp. 593-602
-
-
Garraway, L.A.1
Sellers, W.R.2
-
2
-
-
84947245381
-
Plasma AR and abiraterone-resistant prostate cancer
-
A. Romanel, D. Gasi Tandefelt, V. Conteduca, A. Jayaram, N. Casiraghi, D. Wetterskog, S. Salvi, D. Amadori, Z. Zafeiriou, P. Rescigno, D. Bianchini, G. Gurioli, V. Casadio, S. Carreira, J. Goodall, A. Wingate, R. Ferraldeschi, N. Tunariu, P. Flohr, U. De Giorgi, J. S. de Bono, F. Demichelis, G. Attard, Plasma AR and abiraterone-resistant prostate cancer. Sci. Transl. Med. 7, 312re10 (2015).
-
(2015)
Sci. Transl. Med.
, vol.7
-
-
Romanel, A.1
Gasi Tandefelt, D.2
Conteduca, V.3
Jayaram, A.4
Casiraghi, N.5
Wetterskog, D.6
Salvi, S.7
Amadori, D.8
Zafeiriou, Z.9
Rescigno, P.10
Bianchini, D.11
Gurioli, G.12
Casadio, V.13
Carreira, S.14
Goodall, J.15
Wingate, A.16
Ferraldeschi, R.17
Tunariu, N.18
Flohr, P.19
De Giorgi, U.20
De Bono, J.S.21
Demichelis, F.22
Attard, G.23
more..
-
3
-
-
84933510527
-
Androgen receptor gene aberrations in circulating cell-free DNA: Biomarkers of therapeutic resistance in castration-resistant prostate cancer
-
A. A. Azad, S. V. Volik, A. W. Wyatt, A. Haegert, S. Le Bihan, R. H. Bell, S. A. Anderson, B. McConeghy, R. Shukin, J. Bazov, J. Youngren, P. Paris, G. Thomas, E. J. Small, Y. Wang, M. E. Gleave, C. C. Collins, K. N. Chi, Androgen receptor gene aberrations in circulating cell-free DNA: Biomarkers of therapeutic resistance in castration-resistant prostate cancer. Clin. Cancer Res. 21, 2315-2324 (2015).
-
(2015)
Clin. Cancer Res.
, vol.21
, pp. 2315-2324
-
-
Azad, A.A.1
Volik, S.V.2
Wyatt, A.W.3
Haegert, A.4
Le Bihan, S.5
Bell, R.H.6
Anderson, S.A.7
McConeghy, B.8
Shukin, R.9
Bazov, J.10
Youngren, J.11
Paris, P.12
Thomas, G.13
Small, E.J.14
Wang, Y.15
Gleave, M.E.16
Collins, C.C.17
Chi, K.N.18
-
4
-
-
84930225081
-
Integrative clinical genomics of advanced prostate cancer
-
D. Robinson, E. M. Van Allen, Y. M. Wu, N. Schultz, R. J. Lonigro, J. M. Mosquera, B. Montgomery, M. E. Taplin, C. C. Pritchard, G. Attard, H. Beltran, W. Abida, R. K. Bradley, J. Vinson, X. Cao, P. Vats, L. P. Kunju, M. Hussain, F. Y. Feng, S. A. Tomlins, K. A. Cooney, D. C. Smith, C. Brennan, J. Siddiqui, R. Mehra, Y. Chen, D. E. Rathkopf, M. J. Morris, S. B. Solomon, J. C. Durack, V. E. Reuter, A. Gopalan, J. Gao, M. Loda, R. T. Lis, M. Bowden, S. P. Balk, G. Gaviola, C. Sougnez, M. Gupta, E. Y. Yu, E. A. Mostaghel, H. H. Cheng, H. Mulcahy, L. D. True, S. R. Plymate, H. Dvinge, R. Ferraldeschi, P. Flohr, S. Miranda, Z. Zafeiriou, N. Tunariu, J. Mateo, R. Perez-Lopez, F. Demichelis, B. D. Robinson, M. Schiffman, D. M. Nanus, S. T. Tagawa, A. Sigaras, K. W. Eng, O. Elemento, A. Sboner, E. I. Heath, H. I. Scher, K. J. Pienta, P. Kantoff, J. S. de Bono, M. A. Rubin, P. S. Nelson, L. A. Garraway, C. L. Sawyers, A. M. Chinnaiyan, Integrative clinical genomics of advanced prostate cancer. Cell 161, 1215-1228 (2015).
-
(2015)
Cell
, vol.161
, pp. 1215-1228
-
-
Robinson, D.1
Van Allen, E.M.2
Wu, Y.M.3
Schultz, N.4
Lonigro, R.J.5
Mosquera, J.M.6
Montgomery, B.7
Taplin, M.E.8
Pritchard, C.C.9
Attard, G.10
Beltran, H.11
Abida, W.12
Bradley, R.K.13
Vinson, J.14
Cao, X.15
Vats, P.16
Kunju, L.P.17
Hussain, M.18
Feng, F.Y.19
Tomlins, S.A.20
Cooney, K.A.21
Smith, D.C.22
Brennan, C.23
Siddiqui, J.24
Mehra, R.25
Chen, Y.26
Rathkopf, D.E.27
Morris, M.J.28
Solomon, S.B.29
Durack, J.C.30
Reuter, V.E.31
Gopalan, A.32
Gao, J.33
Loda, M.34
Lis, R.T.35
Bowden, M.36
Balk, S.P.37
Gaviola, G.38
Sougnez, C.39
Gupta, M.40
Yu, E.Y.41
Mostaghel, E.A.42
Cheng, H.H.43
Mulcahy, H.44
True, L.D.45
Plymate, S.R.46
Dvinge, H.47
Ferraldeschi, R.48
Flohr, P.49
Miranda, S.50
Zafeiriou, Z.51
Tunariu, N.52
Mateo, J.53
Perez-Lopez, R.54
Demichelis, F.55
Robinson, B.D.56
Schiffman, M.57
Nanus, D.M.58
Tagawa, S.T.59
Sigaras, A.60
Eng, K.W.61
Elemento, O.62
Sboner, A.63
Heath, E.I.64
Scher, H.I.65
Pienta, K.J.66
Kantoff, P.67
De Bono, J.S.68
Rubin, M.A.69
Nelson, P.S.70
Garraway, L.A.71
Sawyers, C.L.72
Chinnaiyan, A.M.73
more..
-
5
-
-
1842612441
-
Molecular determinants of resistance to antiandrogen therapy
-
C. D. Chen, D. S. Welsbie, C. Tran, S. H. Baek, R. Chen, R. Vessella, M. G. Rosenfeld, C. L. Sawyers, Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10, 33-39 (2004).
-
(2004)
Nat. Med.
, vol.10
, pp. 33-39
-
-
Chen, C.D.1
Welsbie, D.S.2
Tran, C.3
Baek, S.H.4
Chen, R.5
Vessella, R.6
Rosenfeld, M.G.7
Sawyers, C.L.8
-
6
-
-
84885214146
-
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)
-
M. Korpal, J. M. Korn, X. Gao, D. P. Rakiec, D. A. Ruddy, S. Doshi, J. Yuan, S. G. Kovats, S. Kim, V. G. Cooke, J. E. Monahan, F. Stegmeier, T. M. Roberts, W. R. Sellers, W. Zhou, P. Zhu, An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). Cancer Discovery 3, 1030-1043 (2013).
-
(2013)
Cancer Discovery
, vol.3
, pp. 1030-1043
-
-
Korpal, M.1
Korn, J.M.2
Gao, X.3
Rakiec, D.P.4
Ruddy, D.A.5
Doshi, S.6
Yuan, J.7
Kovats, S.G.8
Kim, S.9
Cooke, V.G.10
Monahan, J.E.11
Stegmeier, F.12
Roberts, T.M.13
Sellers, W.R.14
Zhou, W.15
Zhu, P.16
-
7
-
-
84927655173
-
Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors
-
E. J. Chen, A. G. Sowalsky, S. Gao, C. Cai, O. Voznesensky, R. Schaefer, M. Loda, L. D. True, H. Ye, P. Troncoso, R. L. Lis, P. W. Kantoff, R. B. Montgomery, P. S. Nelson, G. J. Bubley, S. P. Balk, M. E. Taplin, Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors. Clin. Cancer Res. 21, 1273-1280 (2015).
-
(2015)
Clin. Cancer Res.
, vol.21
, pp. 1273-1280
-
-
Chen, E.J.1
Sowalsky, A.G.2
Gao, S.3
Cai, C.4
Voznesensky, O.5
Schaefer, R.6
Loda, M.7
True, L.D.8
Ye, H.9
Troncoso, P.10
Lis, R.L.11
Kantoff, P.W.12
Montgomery, R.B.13
Nelson, P.S.14
Bubley, G.J.15
Balk, S.P.16
Taplin, M.E.17
-
8
-
-
84907057471
-
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
-
E. S. Antonarakis, C. Lu, H. Wang, B. Luber, M. Nakazawa, J. C. Roeser, Y. Chen, T. A. Mohammad, Y. Chen, H. L. Fedor, T. L. Lotan, Q. Zheng, A. M. De Marzo, J. T. Isaacs, W. B. Isaacs, R. Nadal, C. J. Paller, S. R. Denmeade, M. A. Carducci, M. A. Eisenberger, J. Luo, AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N. Engl. J. Med. 371, 1028-1038 (2014).
-
(2014)
N. Engl. J. Med.
, vol.371
, pp. 1028-1038
-
-
Antonarakis, E.S.1
Lu, C.2
Wang, H.3
Luber, B.4
Nakazawa, M.5
Roeser, J.C.6
Chen, Y.7
Mohammad, T.A.8
Chen, Y.9
Fedor, H.L.10
Lotan, T.L.11
Zheng, Q.12
De Marzo, A.M.13
Isaacs, J.T.14
Isaacs, W.B.15
Nadal, R.16
Paller, C.J.17
Denmeade, S.R.18
Carducci, M.A.19
Eisenberger, M.A.20
Luo, J.21
more..
-
9
-
-
33645302628
-
The epithelial-mesenchymal transition: New insights in signaling, development, and disease
-
J. M. Lee, S. Dedhar, R. Kalluri, E. W. Thompson, The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J. Cell Biol. 172, 973-981 (2006).
-
(2006)
J. Cell Biol.
, vol.172
, pp. 973-981
-
-
Lee, J.M.1
Dedhar, S.2
Kalluri, R.3
Thompson, E.W.4
-
10
-
-
84929413050
-
Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer
-
H. I. Scher, G. Heller, A. Molina, G. Attard, D. C. Danila, X. Jia, W. Peng, S. K. Sandhu, D. Olmos, R. Riisnaes, R. McCormack, T. Burzykowski, T. Kheoh, M. Fleisher, M. Buyse, J. S. de Bono, Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer. J. Clin. Oncol. 33, 1348-1355 (2015).
-
(2015)
J. Clin. Oncol.
, vol.33
, pp. 1348-1355
-
-
Scher, H.I.1
Heller, G.2
Molina, A.3
Attard, G.4
Danila, D.C.5
Jia, X.6
Peng, W.7
Sandhu, S.K.8
Olmos, D.9
Riisnaes, R.10
McCormack, R.11
Burzykowski, T.12
Kheoh, T.13
Fleisher, M.14
Buyse, M.15
De Bono, J.S.16
|